PubMed · 2014 · 22 citations · 11 references
MedicineMaternal HealthObstetricsMaternal-fetal MedicinePerinatal EpidemiologySubstance Use DisordersPregnancyPrenatal CarePrenatal DevelopmentSubstance Abuse PreventionFamily Medicine Practice ModelsMaternal Substance UseNeonatal Abstinence SyndromeNeonatal Outcomes AssessmentPrenatal Drug ExposurePrenatal Substance ExposureProspective Cohort Data
OBJECTIVE: To document the incidence and outcomes of narcotic use during pregnancy in northwestern Ontario. DESIGN: Three-year prospective cohort study. SETTING: Sioux Lookout and surrounding communities in northwestern Ontario. PARTICIPANTS: A total of 1206 consecutive births in a catchment area of 28 000 First Nations patients. MAIN OUTCOME MEASURES: Incidence of narcotic use, and maternal and neonatal outcomes. RESULTS: Incidence of narcotic use in pregnancy has risen to 28.6% (P < .001) and incidence of neonatal abstinence syndrome has fallen to 18.0% of narcotic-exposed births (P = .003). Daily intravenous drug use is now a common pattern of abuse. CONCLUSION: Narcotic abuse in pregnancy has dramatically increased in northwestern Ontario. Neonatal outcomes have improved as a result of a family medicine-based prenatal and obstetric program that includes a narcotic replacement and tapering program.
11
Neonatal Abstinence Syndrome After Methadone or Buprenorphine Exposure
Hendrée E. Jones, Karol Kaltenbach, Sarah H. Heil et al. · Obstetrical & Gynecological Survey · 2011 · 113 citations
Medicine, Obstetrics, Pharmacology +16
Comparison of methadone and slow‐release morphine maintenance in pregnant addicts
Reinhold Jagsch, Harald Eder, Wolfgang Gombas et al. · Addiction · 1999 · 105 citations